A citation-based method for searching scientific literature

Omar Castaneda-Puglianini, Julio C Chavez. Drugs Context 2021
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
50

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities.
Cirino Botta, Francesco Mendicino, Enrica Antonia Martino, Ernesto Vigna, Domenica Ronchetti, Pierpaolo Correale, Fortunato Morabito, Antonino Neri, Massimo Gentile. Cancers (Basel) 2021
9
25

Is immunotherapy here to stay in multiple myeloma?
Paula Rodríguez-Otero, Bruno Paiva, Monika Engelhardt, Felipe Prósper, Jesús F San Miguel. Haematologica 2017
27
25

IL-10 in myeloma cells.
Takemi Otsuki, Kenichiro Yata, Haruko Sakaguchi, Masako Uno, Tomohiro Fujii, Hideho Wada, Takashi Sugihara, Ayako Ueki. Leuk Lymphoma 2002
36
25

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.
Xinyu Tian, Han Shen, Zhiyang Li, Tingting Wang, Shengjun Wang. J Hematol Oncol 2019
83
25

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
Hequan Li, Yanmei Han, Qiuli Guo, Minggang Zhang, Xuetao Cao. J Immunol 2009
524
25

Multiple myeloma.
Antonio Palumbo, Kenneth Anderson. N Engl J Med 2011
25

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma.
Kristine A Frerichs, Monique C Minnema, Mark-David Levin, Annemiek Broijl, Gerard M J Bos, Marie José Kersten, Tuna Mutis, Christie P M Verkleij, Inger S Nijhof, Patricia W C Maas-Bosman,[...]. Blood Adv 2021
8
25

Immunologic microenvironment and personalized treatment in multiple myeloma.
Marco Rossi, Cirino Botta, Pierpaolo Correale, Pierfrancesco Tassone, Pierosandro Tagliaferri. Expert Opin Biol Ther 2013
32
25

What is trogocytosis and what is its purpose?
Etienne Joly, Denis Hudrisier. Nat Immunol 2003
363
25

Cytotoxic T Cell Responses Induced by CS1/CRT Fusion DNA Vaccine in a Human Plasmacytoma Model.
Xueshi Ye, Wanli Li, Jinwen Huang, Lifei Zhang, Ye Zhang. Front Oncol 2020
1
100

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Ennio Carbone, Paola Neri, Maria Mesuraca, Mariateresa T Fulciniti, Takemi Otsuki, Daniela Pende, Veronika Groh, Thomas Spies, Giuditta Pollio, David Cosman,[...]. Blood 2005
258
25

Checkpoint Inhibition in Myeloma: Opportunities and Challenges.
Federica Costa, Rituparna Das, Jithendra Kini Bailur, Kavita Dhodapkar, Madhav V Dhodapkar. Front Immunol 2018
36
25

Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.
Patrizia Leone, Simona Berardi, Maria Antonia Frassanito, Roberto Ria, Valli De Re, Sebastiano Cicco, Stefano Battaglia, Paolo Ditonno, Franco Dammacco, Angelo Vacca,[...]. Blood 2015
58
25

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee,[...]. Nat Med 2021
53
25


Immunotherapy in myeloma: how far have we come?
Laurens E Franssen, Tuna Mutis, Henk M Lokhorst, Niels W C J van de Donk. Ther Adv Hematol 2019
41
25

Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis.
Lisa C Holthof, Jort J van der Schans, Afroditi Katsarou, Renée Poels, Anne T Gelderloos, Esther Drent, Susan E van Hal-van Veen, Fengzhi Li, Sonja Zweegman, Niels W C J van de Donk,[...]. Clin Cancer Res 2021
13
25

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
Joanna Bartosińska, Joanna Purkot, Agnieszka Karczmarczyk, Michał Chojnacki, Joanna Zaleska, Paulina Własiuk, Norbert Grząśko, Marta Morawska, Adam Walter-Croneck, Lidia Usnarska-Zubkiewicz,[...]. Cells 2021
3
33

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.
Moshe Elkabets, Vera S G Ribeiro, Charles A Dinarello, Suzanne Ostrand-Rosenberg, James P Di Santo, Ron N Apte, Christian A J Vosshenrich. Eur J Immunol 2010
208
25

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.
S Basu, R J Binder, T Ramalingam, P K Srivastava. Immunity 2001
833
25

BCMA-targeting Bispecific Antibody That Simultaneously Stimulates NKG2D-enhanced Efficacy Against Multiple Myeloma.
Yang Wang, Hui Li, Wei Xu, Mingzhu Pan, Chun Qiao, Jialing Cai, Jingjing Xu, Min Wang, Juan Zhang. J Immunother 2020
14
25

Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with monoclonal gammopathy.
Régis T Costello, Anne Boehrer, Carole Sanchez, Delphine Mercier, Céline Baier, Thérèse Le Treut, Gérard Sébahoun. Immunology 2013
45
25

Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
Daeun Ryu, Seok Jin Kim, Yourae Hong, Areum Jo, Nayoung Kim, Hee-Jin Kim, Hae-Ock Lee, Kihyun Kim, Woong-Yang Park. Clin Cancer Res 2020
28
25

High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling.
A Romano, N L Parrinello, V Simeon, F Puglisi, P La Cava, C Bellofiore, C Giallongo, G Camiolo, F D'Auria, V Grieco,[...]. Sci Rep 2020
27
25

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy.
Radek Spisek, Anjli Kukreja, Lin-Chi Chen, Phillip Matthews, Amitabha Mazumder, David Vesole, Sundar Jagannath, Henry A Zebroski, Andrew J G Simpson, Gerd Ritter,[...]. J Exp Med 2007
147
25

Deregulated cytokine network and defective Th1 immune response in multiple myeloma.
M A Frassanito, A Cusmai, F Dammacco. Clin Exp Immunol 2001
72
25

CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis.
Ross Brown, Karieshma Kabani, James Favaloro, Shihong Yang, P Joy Ho, John Gibson, Phillip Fromm, Hayley Suen, Narelle Woodland, Najah Nassif,[...]. Blood 2012
65
25


High Th1/Th2 ratio in patients with multiple myeloma.
Hatsue Ogawara, Hiroshi Handa, Tohru Yamazaki, Takuma Toda, Kensuke Yoshida, Natsumi Nishimoto, Wedad Hamdi Saleh Al-ma'Quol, Yoriaki Kaneko, Takafumi Matsushima, Norifumi Tsukamoto,[...]. Leuk Res 2005
67
25

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.
Masahisa Jinushi, Matthew Vanneman, Nikhil C Munshi, Yu-Tzu Tai, Rao H Prabhala, Jerome Ritz, Donna Neuberg, Kenneth C Anderson, Daniel Ruben Carrasco, Glenn Dranoff. Proc Natl Acad Sci U S A 2008
197
25

The expanding family of regulatory B cells.
Claudia Mauri, Madhvi Menon. Int Immunol 2015
198
25

Macrophage plasticity and polarization: in vivo veritas.
Antonio Sica, Alberto Mantovani. J Clin Invest 2012
25

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.
Almudena García-Ortiz, Yaiza Rodríguez-García, Jessica Encinas, Elena Maroto-Martín, Eva Castellano, Joaquín Teixidó, Joaquín Martínez-López. Cancers (Basel) 2021
38
25

Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma.
Mikiko Ise, Keiko Matsubayashi, Hideki Tsujimura, Kyoya Kumagai. Clin Lymphoma Myeloma Leuk 2016
11
25

Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions.
Chiara Caraccio, Sachi Krishna, Darci J Phillips, Christian M Schürch. Front Immunol 2020
54
25

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Anne J Novak, Jaime R Darce, Bonnie K Arendt, Brandon Harder, Kathy Henderson, Wayne Kindsvogel, Jane A Gross, Philip R Greipp, Diane F Jelinek. Blood 2004
365
25


Cancer immunoediting and immune dysregulation in multiple myeloma.
Kyohei Nakamura, Mark J Smyth, Ludovic Martinet. Blood 2020
49
25

Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
Zhitao Wang, Lulu Zhang, Huiping Wang, Shudao Xiong, Yanli Li, Qianshan Tao, Weihua Xiao, Hui Qin, Yiping Wang, Zhimin Zhai. Cancer Immunol Immunother 2015
58
25

TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Chelsea Hope, Samuel J Ollar, Erika Heninger, Ellen Hebron, Jeffrey L Jensen, Jaehyup Kim, Ioanna Maroulakou, Shigeki Miyamoto, Catherine Leith, David T Yang,[...]. Blood 2014
67
25

CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Fabian Flores-Borja, Anneleen Bosma, Dorothy Ng, Venkat Reddy, Michael R Ehrenstein, David A Isenberg, Claudia Mauri. Sci Transl Med 2013
463
25

How regulatory T cells work.
Dario A A Vignali, Lauren W Collison, Creg J Workman. Nat Rev Immunol 2008
25

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.
Mónica Bernal, Pilar Garrido, Pilar Jiménez, Rafael Carretero, Manuel Almagro, Pilar López, Pilar Navarro, Federico Garrido, Francisco Ruiz-Cabello. Hum Immunol 2009
42
25

Coordinated regulation of myeloid cells by tumours.
Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Vincenzo Bronte. Nat Rev Immunol 2012
25


Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.
Ailing Lu, Manuel A Pallero, Weiqi Lei, Huixian Hong, Yang Yang, Mark J Suto, Joanne E Murphy-Ullrich. Am J Pathol 2016
41
25

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Bin-Zhi Qian, Jiufeng Li, Hui Zhang, Takanori Kitamura, Jinghang Zhang, Liam R Campion, Elizabeth A Kaiser, Linda A Snyder, Jeffrey W Pollard. Nature 2011
25

Immune escape mechanisms as a guide for cancer immunotherapy.
Gregory L Beatty, Whitney L Gladney. Clin Cancer Res 2015
530
25

T cell exhaustion.
E John Wherry. Nat Immunol 2011
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.